Comparison of Eohilia With Dupixent on Esophagus Diameter in Patients With Eosinophilic Esophagitis.

NCT07358234 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ENROLLING_BY_INVITATION

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Eosinophilic Esophagitis (EoE)

Interventions

DRUG: Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT]
DRUG: budesonide oral suspension

Sponsor

Mayo Clinic

Collaborators

[object Object]